TOBAM’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,846
| Closed | -$516K | – | 261 |
|
|
2025
Q3 | $516K | Buy |
6,846
+1,896
| +38% | +$130K | 0.19% | 88 |
|
|
2025
Q2 | $341K | Buy |
+4,950
| New | +$325K | 0.13% | 95 |
|
|
2025
Q1 | – | Sell |
-4,348
| Closed | -$195K | – | 269 |
|
|
2024
Q4 | $195K | Sell |
4,348
-1,085
| -20% | -$60.9K | 0.06% | 159 |
|
|
2024
Q3 | $342K | Sell |
5,433
-2,983
| -35% | -$174K | 0.06% | 148 |
|
|
2024
Q2 | $497K | Sell |
8,416
-2,557
| -23% | -$160K | 0.08% | 114 |
|
|
2024
Q1 | $875K | Buy |
10,973
+468
| +4% | +$35.7K | 0.08% | 106 |
|
|
2023
Q4 | $829K | Sell |
10,505
-1,618
| -13% | -$115K | 0.07% | 95 |
|
|
2023
Q3 | $846K | Buy |
12,123
+3,952
| +48% | +$280K | 0.07% | 108 |
|
|
2023
Q2 | $565K | Sell |
8,171
-1,696
| -17% | -$121K | 0.04% | 137 |
|
|
2023
Q1 | $733K | Buy |
9,867
+551
| +6% | +$46.2K | 0.05% | 127 |
|
|
2022
Q4 | $868K | Sell |
9,316
-14,369
| -61% | -$1.39M | 0.06% | 112 |
|
|
2022
Q3 | $2.26M | Sell |
23,685
-2,421
| -9% | -$240K | 0.16% | 94 |
|
|
2022
Q2 | $2.42M | Sell |
26,106
-4,983
| -16% | -$486K | 0.15% | 93 |
|
|
2022
Q1 | $3.15M | Buy |
31,089
+27,028
| +666% | +$2.84M | 0.16% | 103 |
|
|
2021
Q4 | $419K | Sell |
4,061
-417
| -9% | -$38.5K | 0.02% | 153 |
|
|
2021
Q3 | $380K | Hold |
4,478
| – | – | 0.02% | 157 |
|
|
2021
Q2 | $374K | Hold |
4,478
| – | – | 0.02% | 166 |
|
|
2021
Q1 | $337K | Hold |
4,478
| – | – | 0.01% | 159 |
|
|
2020
Q4 | $306K | Hold |
4,478
| – | – | 0.01% | 165 |
|
|
2020
Q3 | $262K | Buy |
+4,478
| New | +$279K | 0.01% | 154 |
|
|
2018
Q4 | – | Sell |
-25,126
| Closed | -$1.98M | – | 160 |
|
|
2018
Q3 | $1.98M | Sell |
25,126
-48,544
| -66% | -$3.47M | 0.08% | 117 |
|
|
2018
Q2 | $4.74M | Sell |
73,670
-330,332
| -82% | -$21.8M | 0.2% | 92 |
|
|
2018
Q1 | $25.1M | Sell |
404,002
-36,228
| -8% | -$2.6M | 1.03% | 35 |
|
|
2017
Q4 | $31.9M | Buy |
440,230
+65,148
| +17% | +$4.74M | 1.38% | 21 |
|
|
2017
Q3 | $30.5M | Buy |
375,082
+72,034
| +24% | +$5.7M | 1.15% | 36 |
|
|
2017
Q2 | $24.4M | Buy |
303,048
+142,706
| +89% | +$11.3M | 0.91% | 47 |
|
|
2017
Q1 | $12.6M | Buy |
160,342
+105,001
| +190% | +$8.38M | 0.49% | 61 |
|
|
2016
Q4 | $4.37M | Buy |
+55,341
| New | +$4.48M | 0.18% | 74 |
|
Other funds holding CVS
TOBAM's CVS Position: Q4 2025 in Review
TOBAM sold out of CVS Health (CVS) in Q4 2025, closing a stake of 6,846 shares — an estimated $516K sold.
TOBAM first reported a position in CVS in Q4 2016 and held it in 28 quarters. The position peaked at $31.9M in Q4 2017. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- TOBAM reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- TOBAM sold 6,846 CVS Health shares in Q4 2025, an estimated $516K.
- TOBAM first reported a position in CVS Health in Q4 2016 and held it in 28 quarters.
- TOBAM's CVS Health position peaked at $31.9M in Q4 2017.
- 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on TOBAM's 13F filing for Q4 2025, filed 2 Mar 2026.